Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 063709/0899 | |
| Pages: | 42 |
| | Recorded: | 05/18/2023 | | |
Attorney Dkt #: | BB.388; BB.424; BB.424D1 |
Conveyance: | PATENT TRANSFER AGREEMENT |
|
Total properties:
3
|
|
Patent #:
|
|
Issue Dt:
|
01/30/2018
|
Application #:
|
14787416
|
Filing Dt:
|
10/27/2015
|
Publication #:
|
|
Pub Dt:
|
04/28/2016
| | | | |
Title:
|
Treatment of Insulin Resistance Through Inhibitors of Transcription Factor TSC22D4
|
|
|
Patent #:
|
|
Issue Dt:
|
06/09/2020
|
Application #:
|
15545104
|
Filing Dt:
|
07/20/2017
|
Publication #:
|
|
Pub Dt:
|
01/25/2018
| | | | |
Title:
|
OLIGONUCLEOTIDE SEQUENCES TARGETING TRANSCRIPTION FACTOR TSC22D4 FOR THE TREATMENT OF INSULIN RESISTANCE
|
|
|
Patent #:
|
|
Issue Dt:
|
07/06/2021
|
Application #:
|
16862930
|
Filing Dt:
|
04/30/2020
|
Publication #:
|
|
Pub Dt:
|
08/13/2020
| | | | |
Title:
|
OLIGONUCLEOTIDE SEQUENCES TARGETING TRANSCRIPTION FACTOR TSC22D4 FOR THE TREATMENT OF INSULIN RESISTANCE
|
|
Assignee
|
|
|
INGOLSTÄDTER LANDSTRASSE 1 |
NEUHERBERG, GERMANY 85764 |
|
Correspondence name and address
|
|
DAVID R. SALIWANCHIK
|
|
SALIWANCHIK, LLOYD & EISENSCHENK
|
|
P.O. BOX 142950
|
|
GAINESVILLE, FL 32614-2950
|
Search Results as of:
05/30/2024 08:46 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|